Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes

We examined associations of advanced glycation end products (AGEs) with renal function loss (RFL) and its structural determinants in American Indians with type 2 diabetes. Data were from a 6-year clinical trial that assessed renoprotective efficacy of losartan. Participants remained under observatio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes
Main Authors: Saulnier, Pierre-Jean, Wheelock, Kevin M., Howell, Scott, Weil, E. Jennifer, Tanamas, Stephanie K., Knowler, William C., Lemley, Kevin V., Mauer, Michael, Yee, Berne, Nelson, Robert G., Beisswenger, Paul J.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2016
Teme:
Complications
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5127241/
https://ncbi.nlm.nih.gov/pubmed/27609106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db16-0310
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki